Construction and characterization of recombinant human adenovirus type 5 expressing foot-and-mouth disease virus capsid proteins of Indian vaccine strain, O/IND/R2/75

Veterinary World

Volumn 8, Issue 2, 2015, Pages 147-155

  Kumar, Ramesh ^a   Sreenivasa, B P ^a   Tamilselvan, R P ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Foot and mouth disease; Growth kinetics; Recombinant hAd5; Thermostability; Virus like particles

Indexed keywords

ADENOVIRIDAE; FOOT-AND-MOUTH DISEASE VIRUS; HUMAN ADENOVIRUS TYPE 5; MIRIDAE;

EID: 84923064681     PISSN: 09728988     EISSN: 22310916     Source Type: Journal    
DOI: 10.14202/vetworld.2015.147-155     Document Type: Article

References (42)

1. Grubman, M.J. and Baxt, B. (2004) Foot-and-mouth disease. Clin. Microbiol. Rev., 17: 465-493.
2. Sobrino, F., Saiz, M., Jimmenez-Clavero, M.A., Nunez, J.I., Rosas, M.F., Baranowsky, E. and Ley, V. (2001) Foot-andmouth disease virus: A long known virus, but a current threat. Vet. Res., 32(1): 1-30.
3. th ed Paris, France.
4. Charleston, B., Bankowski, B., Gubbins, S., Chase- Topping, M.E., Schley, D., Howey, R., Barnett, P.V., Gibson, D., Juleff, N.D. and Woolhouse, M.E.J. (2011) Relationship between clinical symptoms and transmission of an infectious disease and the implications for control. Science, 332(6030): 726-729.
5. rd ed. Philadelphia, PA, Lippincott-Raven. p609-654.
6. Pilipenko, E.V., Maslova, S.V., Sinyakov, A.N. and Agol, V.I. (1992) Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: A proposal for the existence of tRNA-like terminal structures. Nucl. Acids. Res., 20(7): 1739-1745.
7. Anon (2010) Annual Report (2009-2010). Project Directorate on Foot and Mouth Disease. Mukteswar, India.
8. Geale, D.W., Barnett, P.V., Clarke, G.W., Davis, J. and Kasar, T.R. (2013) A review of OIE country status recovery using vaccinate to live versus vaccinate to die foot-andmouth disease response policies II: Waiting periods after emergency vaccination in FMD free countries. Transbound. Emerg. Dis., doi:10.1111/tbed.12165.
9. Jennings, G.T. and Bachmann, M.F. (2008) The coming of age of virus-like particle vaccines. Biol. Chem., 389(5): 521-536.
10. Plummer, E.M. and Manchester, M. (2011) Viral nanoparticles and virus-like particles: Platforms for contemporary vaccine design. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 3(2): 174-196.
11. Abrams, C.C., King, A.M, and Belsham, G.J. (1995) Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J. Gen. Virol., 76: 3089-3098.
12. Mason, P.W., Chinsangaram, J., Moraes, M.P., Mayr, G.A. and Grubman, M.J. (2003) Engineering better vaccines for foot-and-mouth disease. Dev. Biol., 114: 79-88.
13. Lewis, S.A., Morgan, D.O. and Grubman, M.J. (1991) Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: Induction of a neutralizing antibody response in guinea pigs. J. Virol., 65(12): 6572-6580.
14. Li, Z., Yi, Y., Yin, X., Zhang, Z. and Liu, J. (2008) Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PloS One, 3(5): e2273.
15. Rweyemamu, M.M., Terry, G. and Pay, T.W. (1979) Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch. Virol., 59(1-2): 69-79.
16. Guo, C., Zhang, C., Zheng, H. and Huang, Y. (2013) Recombinant adenovirus expression of FMDV P1-2A and 3C protein and its immune response in mice. Res. Vet. Sci., 95(2): 736-741.
17. Mayr, G.A., Chinsangaram, J. and Grubman, M.J. (1999) Development of replication-deficient adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology, 263(2): 496-506.
18. Kushnir, N., Streatfield, S. and Yusibov, V. (2012) Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development. Vaccine, 31(1): 58-83
19. Silva, A.C., Fernades, P., Sousa, M.F. and Alves, P.M. (2014) Scalable production of adenovirus vectors. Methods. Mol. Biol., 1089: 175-196.
20. Wald, W.S. and Toth, K. (2014) Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr. Gene. Ther., 13(6): 421-433.
21. Luo, J., Deng, Z.L., Luo, X., Tang, N., Song, W.X., Chen, J., Sharff, KA., Luu, HH., Haydon, RC., Kinzler, KW., Vogelstein, B., He, TC. (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc., 2(5): 1236-1247.
22. Deal, C., Pekosz, A. and Ketner, G. (2013) Prospects for oral replicating adenovirus-vectored vaccines. Vaccine, 31(32): 3236-3243.
23. Odondo, B.O. (2014) The influence of delivery vectors on HIV vaccine efficacy. Front. Microbiol., 5: 439.
24. Brake, D.A., McIlhaney, M., Miller, T., Christianson, K., Keene, A., Lohnas, G., Purcell, C., Neilan, J., Schutta, C., Barrera, J., Burrage, T., Brough, DE. and Butman, BT. (2012) Human adenovirus vectored foot-and-mouth disease vaccines: Establishment of a vaccine product profile through in vitro testing. Dev. Biol., 134: 123-133.
25. Romanutti, C., D'Antuono, A., Palacios, C., Quattrocchi, V., Zamorano, P., La Torre, J. and Mattion, N. (2013) Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus. Vet. Microbiol., 165(3-4): 333-340.
26. Lu, Z., Bao, H., Cao, Y., Sun, P., Guo, J., Li, P., Bai, X., Chen, Y., Xie, B., Li, D., Liu, Z. and Xie, Q. (2008) Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease. Vaccine, 26 Suppl 6: G48-53.
27. Pacheco, J.M., Brum, M.C., Moraes, M.P., Golde, W.T. and Grubman, M.J. (2005) Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology, 337(2): 205-209.
28. Pena, L., Moraes, M.P., Koster, M., Burrage, T., Pacheco, J.M., Segundo, F.D. and Grubman, M.J. (2008) Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine, 26(45): 5689-5699.
29. Moraes, M.P., Segundo, F.D., Dias, C.C., Pena, L. and Grubman, M.J. (2011) Increased efficacy of an adenovirus- vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Vaccine, 29(51): 9431-9440.
30. rd ed. New York, Cold Spring Harbor. p1-117.
31. Reed, L.J. and Muench, H. (1938) A simple method for estimation of fifty percent end point. Am. J. Hyg., 27(3): 493-497.
32. Golde, W.T., Pacheco, J.M., Duque, H., Doel, T., Penfold, B., Ferman, G.S., Gregg, D.R. and Rodriguez, L.L. (2005) Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. Vaccine, 23(50): 5775-5782.
33. Sanz-Parra, A., Jimenez-Clavero, M.A., Garcia-Briones, M.M., Blanco, E., Sobrino, F. and Ley, V. (1999) Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology, 259(1): 129-134.
34. Korrapati, A.B., Swaminathan, G., Singh, A., Khanna, N. and Swaminathan, S. (2012) Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue viruses. PLoS. Negl. Trop. Dis., 6(7): e1735.
35. Barouch, D.H. and Picker, L.J. (2014) Novel vaccine vectors for HIV-1. Nat. Rev. Microbiol., 12(11): 765-771.
36. Bette, A., Prevec, L. and Graham, F. (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol., 67(10): 5911-5921.
37. Saha, B., Wong, C.M. and Parks, R.J. (2014) The Adenovirus genome contributes to the structural stability of the virion. Viruses, 6(9): 3563-3583.
38. Porta, C., Xu, X., Loureiro, S., Paramasivam, S., Ren, J., Al-Khalil, T., Burman, A., Jackson, T., Belsham, GJ., Curry, S., Lomonossoff, GP., Parida, S., Paton, D., Li, Y., Wilsden, G., Ferris, N., Owens, R., Kotecha, A., Fry, E., Stuart, DI., Charleston, B. and Jones, IM. (2013) Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. J. Virol. Methods, 187(2): 406-412.
39. Torres, J.M., Alonso, C., Ortega, A., Mittal, S., Graham, F. and Enjuanes, L. (1996) Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J. Virol., 70(6): 3770-3780.
40. Xue, C., Tian, X., Li, X., Zhou, Z., Su, X. and Zhou, R. (2014) Construction and characterization of a recombinant adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon. Virus. Res., 183: 67-74.
41. Hehir, K.M., Armentano, D., Cardoza, L.M., Choquette, T.L., Berthelette, P.B., White, G.A., Couture, L.A., Everton, M.B., Keegan, J., Martin, J.M., Pratt, D.A., Smith, M.P., Smith, A.E., Wadsworth, S.C. (1996) Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J. Virol., 70(12): 8459-8467.
42. Liu, J., Nian, QG., Zhang, Y., Xu, LJ., Hu, Y., Li, J., Deng, YQ., Zhu, SY., Wu, XY., Qin, ED., Jiang, T. and Qin, CF. (2014) In vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14. PLoS One, 9(6): e100665.